Indirect Electrothermal Atomization Atomic Absorption Spectrometric Determination of the Drug Desferrioxamine in Some Pharmaceutical Preparations Using Vanadium (V) as a Mediating Element
 
More details
Hide details
1
Department of Chemistry, College of Science for Women, University of Baghdad, Jadiryia, Baghdad, Iraq
2
Department of Chemistry, College of Science, University of Baghdad, Jadiryia, Baghdad, Iraq
CORRESPONDING AUTHOR
Zuhair A-A. Khammas   

Department of Chemistry, College of Science for Women, University of Baghdad, Jadiryia, Baghdad, Iraq
Publication date: 2017-10-06
 
Eurasian J Anal Chem 2009;4(3):257–269
 
KEYWORDS
ABSTRACT
A method has been developed for the determination of the drug Desferrioxamine (DFOM) in some pharmaceuticals using indirect electrothermal atomic absorption spectrometry (ETAAS) supplied with zirconium-coated graphite tube and V (V) as a mediating metal. Vanadium (V) forms a chelate complex with (DFOM) at pH range 1-1.5 which could be extracted with benzyl alcohol under certain experimental conditions. Aliquots of the extracts are injected into the coated graphite furnace and the atomic absorption signals are measured. A standard calibration graph was constructed and from which several parameters and figures of merit were found, such as: linear range (0.5-19 μg mL–1) of DFOM, relative standard deviation (1.44-1.68%); low of detection (0.12 μg mL–1)sensitivity. (424.2 pg), recovery %( 101.57± 0.147) and relative error (1.57%). The mole ratio method has been used to determine the structure of chelate DFOM: V (V) and found to be 1:1. The developed procedure is applied to analyze DFOM in several commercially available pharmaceuticals using direct and standard additions methods and results are comparable. All statistical calculations are implemented via a Minitab software version 11.
 
REFERENCES (21)
1.
Chiodo A A, Alberti P W, Sher G D ,Francombe W H, Tyler B (1997) Desferrioxamine ototoxicity in an adult transfusion-dependent population. J Otolaryngol 26 (2): 116.
 
2.
Savory J, Exley C, Forbes W F (1996) Can the controversy of the role of aluminum in Alzheimer's disease is resolved? What are the suggested approaches to this controversy and methodological issues to be considered. J Toxicol Enviorn Health A 48(6): 615.
 
3.
Malluche H H, Smith A J, Abreo K, Faugere M C (1983) the use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure. N Engl J Med 311(3): 140.
 
4.
British Pharmacopoeia (1999) Vol. 1, H.M. Stationary Office, London pp. 391.
 
5.
Kraemer H J, Breithaupt H (1998) Quantification of desferrioxamine, ferrioxamine and aluminoxamine by post-column derivatization high-performance liquid chromatography: Non-linear calibration resulting from second-order reaction kinetics, J Chromatogr B 710(1-2):192.
 
6.
Gower J D, Healing G, Green C J (1989) Determination of desferrioxamine-available iron in biological tissues by high-pressure liquid chromatography, Anal Biochem 180(1): 126.
 
7.
Romero R A, Day J P (1985) Polarographic determination of desferrioxamine B in dialysis sample. Trace Elem Med 2(1):1.
 
8.
Razak O A, Belal S F, Bedair M M, Haggag R S (2003) The utilization of copper(II) phosphate for the anodic stripping voltammetric assay of alendronate sodium, desferrioxamine mesylate and lisinopril. Talanta 59(5 ): 1061.
 
9.
Neubauer U, Furrer G (1999) The use of voltammetry for sorption studies of heavy metals on mineral surfaces in presence of the siderophore desferrioxamine B. Anal Chim Acta 392(2):159.
 
10.
Bourdon S, Houze P R (1987) Quantification of desferrioxamine in blood plasma by inductively coupled plasma atomic emission spectrometry. Clin Chim 33(1): 132.
 
11.
Haese Patrick D, Lamberts C, Ludwing V, Marc E (1989) Indirect measurement of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine by Zeeman atomic absorption spectrometry. Clin Chem 35(5): 884.
 
12.
Al-Ayash AS, Khammas ZA-A and Jasim F (2008) Determination of Desferrioxamine in the Drug Desferal as DFOM-Au(III) complex by Using Indirect Electrothermal Atomic Absorption Spectrometry and Other Techniques. Um-Salama Science J 5(3): 409.
 
13.
Clark E R, Yacoub A K (1984) indirect determination of organic compounds by atomic-absorption spectrophotometry. Talanta 31(1):15.
 
14.
Hassan S S M (1984) Organic Analysis Using Atomic Absorption Spectrometry. Ellis Hardwood Ltd. Chichester, pp 242.
 
15.
Issa M M, Nejem R M, Al-Kholy M , El-Abadla N S , Halles, R S, Saleh A A (2008) An Indirect Absorption Spectrometric Determination of Ciprofloxacin, Amoxicillin and Diclofenac sodium in Pharmaceutical Formulations. J Serbian Chem Soc 73(5): 569.
 
16.
Shamil L, Jasim F, Mustafa A A, Khammas ZA-A (2001) Indirect ET-AAS Spectrophotometric Determination of Diphenhydramine Hydrochloride in Some Pharmaceutical Preparation using Rhenium as Enhancing Coil. Iraqi J Sci 42A(1): 88.
 
17.
Khammas Z A-A and Jasim F (2001) Determination of Gallium in Biotite and Bauxite with ET-AAS Using Zr-carbide Coated Graphite Tube and Pd Matrix Modifier. Iraqi J Sci 42A (1): 87.
 
18.
Buglyo P, Culddu N, Kiss T S, Micera F, Sanna D (1995) Vanadium (IV) and Vanadium(V) complexes of deferoxamine B in Aqueous solutions. J Inorg Biochem 60(1): 45.
 
19.
Kellner R, Mermet, J-M Otto M, Widmer H M (1998) Analytical Chemistry, WilleyVCH Verlag GmbH, D69469 Weinheim, p.761.
 
20.
Menéndez-Fraga B, Blanco-González E, Sanz-Medel A, Cannata-Andía J B (1997) Micellar versus reversed phase liquid chromatography for the determination of desferrioxamine and its chelates with aluminium and iron in uremic serum. Talanta 45(1): 25-33.
 
21.
Allain P, Mauras Y, Beaudeau G, Hingouet P (1986) Indirect micro- scale method for the determination of desferrioxamine and its aluminium and iron chelated forms in biological samples by atomic absorption spectrometry with electrothermal atomization. Analyst 111(5): 531.
 
eISSN:1306-3057